陝西麥科奧特醫藥科技股份有限公司（“麦科医药-B”）于2026年8月4日发布2026年7月股份变动月报表，报告期为截至2026年7月31日。公告显示，公司在港交所（代码：02335）上市的普通股（H股）数量为280,071,100股，面值每股人民币0.02元，相应注册股本合计5,601,422元人民币（约560.14万元）；未在港交所上市的内资股数量为51,669,250股，面值每股人民币0.02元，对应注册股本1,033,385元人民币（约103.34万元）。公司注册股本合计为6,634,807元人民币（约663.48万元）。
报告期内，公司及其库藏股数量均未发生变动，H股及内资股发行量分别保持280,071,100股和51,669,250股不变，合计331,740,350股。公司表示已满足各类股份的香港联交所最低公众持股量要求，并确认遵守香港联交所《上市规则》及相关法律法规。公告由执行董事王冰签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.